The University of Iowa Health Care has joined a new Phase 2 clinical trial that will test booster vaccines in various combinations to determine which provide the best immune response against existing and emerging COVID-19 variants.
The University of Iowa Health Care has joined a new Phase 2 clinical trial that will test booster vaccines in various combinations to determine which provide the best immune response against existing and emerging COVID-19 variants.
The University of California San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
UC San Diego joined a Phase II clinical trial to evaluate additional COVID-19 booster shots to see if different vaccine regimens can broaden immune responses in adults, it was announced Wednesday.